Export 2624 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
E. J. Thompson, Wu, H., Melloni, C., Balevic, S., Sullivan, J. E., Laughon, M., Clark, K. M., Kalra, R., Mendley, S., Payne, E. H., Erinjeri, J., Gelber, C. E., Harper, B., Cohen-Wolkowiez, M., and Hornik, C. P., Population Pharmacokinetics of Doxycycline in Children., Antimicrob Agents Chemother, 2019.
D. J. S. Thompson and Dean, C. B., Imputation using Longitudinal Data in Interval-Censored Survival Data. Fort Collins, CO, 2010.
D. J. S. Thompson, Barron, K., Whitcup, S., and Robinson, M., The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis, Ocular Immunology & Inflammation, vol. 10, pp. 83-91, 2002.
H. Tillman, S Johnston, C., Farrant, M., Barsan, W., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., and J Easton, D., Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial., JAMA Neurol, vol. 76, no. 7, pp. 774-782, 2019.
A. K. Tisdale, Agrón, E., Sunshine, S. B., Clemons, T. E., Ferris, F. L., and Chew, E. Y., Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39., JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
J. L. Tiwari, Schneider, B., Barton, F., and Anderson, S. A., Islet cell transplantation in type 1 diabetes: an analysis of efficacy outcomes and considerations for trial designs., Am J Transplant, vol. 12, no. 7, pp. 1898-907, 2012.
J. Tiwari, Schneider, B., Barton, F., and Anderson, S., Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from the Collaborative Islet Transplant Registry (CITR), in The 2012 Joint Statistical Meetings, San Diego, CA, 2012.
J. L. Tiwari, Schneider, B., Barton, F., and Anderson, S. A., Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Efficacy Outcomes and Considerations for Trial Designs, Am J Transplant, vol. 12, pp. 1898-1907, 2012.
B. Tock, Zwiebel, J. A., and Schoenfeldt, M., Clinical trials referral resource. Current clinical trials of G3139., Oncology (Williston Park), vol. 17, no. 9, pp. 1244-6, 1251-3, 1258, 2003.
J. Tolar, H Deeg, J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels., Biol Blood Marrow Transplant, vol. 18, no. 7, pp. 1007-11, 2012.
J. Tolar, Deeg, H. J., Arai, S., Horwitz, M., Antin, J. H., McCarty, J. M., Adams, R. H., Ewell, M., Leifer, E. S., Gersten, I. D., Carter, S. L., Horowitz, M. M., Nakamura, R., Pulsipher, M. A., Difronzo, N. L., Confer, D. L., Eapen, M., and Anderlini, P., Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
M. R. Tomblyn, Ewell, M., Bredeson, C., Kahl, B. S., Goodman, S. A., Horowitz, M. M., Vose, J. M., Negrin, R. S., and Laport, G. G., Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response., Biol Blood Marrow Transplant, vol. 17, no. 7, pp. 1051-7, 2011.
M. Tomblyn, Ewell, M., Bredeson, C., Kahl, B., Goodman, S., Horowitz, M., Vose, J., Negrin, R., and Laport, G., Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response, Biol Blood Marrow Transplant, vol. 17, pp. 1051-1057, 2011.
B. Toy, Agron, E., Nigam, D., Chew, E., and Wong, W. T., Longitudinal Analysis of Retinal Hemangioblastomatosis and Visual Function in Ocular Von Hippel-Lindau Disease, Opthalmology, vol. 119, pp. 2622-2630, 2012.
B. C. Toy, Agron, E., Nigam, D. L., Chew, E. Y., and Wong, W. T., Longitudinal Analysis of Retinal Hemangioblastomatosis and Visual Function in Ocular von Hippel Lindau Disease, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2011.
B. C. Toy, Agrón, E., Nigam, D., Chew, E. Y., and Wong, W. T., Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease., Ophthalmology, vol. 119, no. 12, pp. 2622-30, 2012.
B. Trachtenberg, Velazquez, D., Williams, A., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J., Heldman, A., and Hare, J., Rationale and Design of the Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) Trial [..], Am Heart J, vol. 161, pp. 487-493, 2011.
B. Trachtenberg, Velazquez, D. L., Williams, A. R., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J. Pablo, Heldman, A. W., and Hare, J. M., Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, Am Heart J, vol. 161, no. 3, pp. 487-93, 2011.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., C Hay, M., Wolff, M., She, D., and Cox, M. M. J., Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults., J Infect Dis, vol. 193, no. 9, pp. 1223-8, 2006.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans, Vaccine, vol. 19, pp. 1732-1737, 2001.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults, J Infect Dis, vol. pii: jiu33, 2014.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults., J Infect Dis, vol. 210, no. 11, pp. 1763-71, 2014.
J. J. Treanor, Campbell, J., Zangwill, K. M., Rowe, T., and Wolff, M. C., Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, N Engl J Med, vol. 354, pp. 1343-1351, 2006.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults., Vaccine, vol. 20, no. 7-8, pp. 1099-105, 2002.
J. J. Treanor, Campbell, J. D., Zangwill, K. M., Rowe, T., and Wolff, M., Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine., N Engl J Med, vol. 354, no. 13, pp. 1343-51, 2006.